Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


03.09.2018

1 BMJ
1 Clin Infect Dis
1 Infect Immun
2 J Infect Dis
3 Lancet
4 Lancet Child Adolesc Health
5 Lancet Infect Dis
3 N Engl J Med
1 Pediatr Infect Dis J
1 PLoS Biol
3 PLoS One
1 Science
15 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. DYER O
    Vaccine safety: Russian bots and trolls stoked online debate, research finds.
    BMJ. 2018;362:k3739.
    PubMed     Text format    


    Clin Infect Dis

  2. USUF E, Bottomley C, Bojang E, Cox I, et al
    Persistence of nasopharyngeal pneumococcal vaccine serotypes and increase of non-vaccine serotypes among vaccinated infants and their mothers five years after PCV13 introduction in The Gambia.
    Clin Infect Dis. 2018 Aug 24. pii: 5079135. doi: 10.1093.
    PubMed     Text format     Abstract available


    Infect Immun

  3. LU YJ, Oliver E, Zhang F, Pope C, et al
    Screening for Th17-dependent pneumococcal vaccine antigens: comparison of murine and human cellular immune responses.
    Infect Immun. 2018 Aug 27. pii: IAI.00490-18. doi: 10.1128/IAI.00490.
    PubMed     Text format     Abstract available


    J Infect Dis

  4. LI Z, Chang P, Xu J, Tan C, et al
    A Streptococcus suis live vaccine suppresses streptococcal toxic shock-like syndrome and provides sequence type independent protectionTITLE.
    J Infect Dis. 2018 Aug 27. pii: 5081797. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. WEINBERG A, Popmihajlov Z, Schmader KE, Johnson MJ, et al
    Persistence of varicella-zoster virus cell-mediated immunity after the administration of a second dose of live herpes zoster vaccine.
    J Infect Dis. 2018 Aug 28. pii: 5084879. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet

  6. HAYFLICK L
    Subject of The Vaccine Race offers perspective on errors.
    Lancet. 2018;392:633-634.
    PubMed     Text format    

  7. GREEN A
    HPV vaccine to be offered to boys in England.
    Lancet. 2018;392:374.
    PubMed     Text format    

  8. YUAN X
    China's vaccine production scare.
    Lancet. 2018;392:371.
    PubMed     Text format    


    Lancet Child Adolesc Health

  9. COWLING BJ, Chiu SS
    Efficacy of inactivated influenza vaccines in young children.
    Lancet Child Adolesc Health. 2018;2:307-308.
    PubMed     Text format    

  10. BRYAN P, Seabroke S, Wong J, Donegan K, et al
    Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study.
    Lancet Child Adolesc Health. 2018;2:395-403.
    PubMed     Text format     Abstract available

  11. CLAEYS C, Zaman K, Dbaibo G, Li P, et al
    Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons.
    Lancet Child Adolesc Health. 2018;2:338-349.
    PubMed     Text format     Abstract available

  12. BETTINGER JA
    Reassuring safety data from the UK multicomponent meningococcal group B vaccine (4CMenB) programme.
    Lancet Child Adolesc Health. 2018;2:380-381.
    PubMed     Text format    


    Lancet Infect Dis

  13. BARNES GL, Bines JE
    Single-dose rotavirus vaccine at birth: is it effective or safe? - Authors' reply.
    Lancet Infect Dis. 2018;18:948-949.
    PubMed     Text format    

  14. TURNER HC, Thwaites GE, Clapham HE
    Vaccine-preventable diseases in lower-middle-income countries.
    Lancet Infect Dis. 2018;18:937-939.
    PubMed     Text format    

  15. DESMET S, Peetermans W, Lagrou K
    Switch in childhood pneumococcal vaccine in Belgium.
    Lancet Infect Dis. 2018;18:945-946.
    PubMed     Text format    

  16. LUQUERO FJ, Azman AA
    Protection of young children with cholera vaccine.
    Lancet Infect Dis. 2018;18:947-948.
    PubMed     Text format    

  17. LU HL, Goyal H, Xu HG
    Single-dose rotavirus vaccine at birth: is it effective or safe?
    Lancet Infect Dis. 2018;18:948.
    PubMed     Text format    


    N Engl J Med

  18. BLAKE IM, Pons-Salort M, Molodecky NA, Diop OM, et al
    Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
    N Engl J Med. 2018;379:834-845.
    PubMed     Text format     Abstract available

  19. PALLANSCH MA
    Ending Use of Oral Poliovirus Vaccine - A Difficult Move in the Polio Endgame.
    N Engl J Med. 2018;379:801-803.
    PubMed     Text format    

  20. PAULES CI, Marston HD, Bloom ME, Fauci AS, et al
    Tickborne Diseases - Confronting a Growing Threat.
    N Engl J Med. 2018;379:701-703.
    PubMed     Text format    


    Pediatr Infect Dis J

  21. OLSON D, Rick AM, Krager S, Lamb M, et al
    Vaccine Demand and Willingness-to-Pay for Arbovirus Vaccines: A Cross Sectional Survey in Rural Guatemala.
    Pediatr Infect Dis J. 2018 Aug 27. doi: 10.1097/INF.0000000000002169.
    PubMed     Text format     Abstract available


    PLoS Biol

  22. BYRNE G, O'Rourke SM, Alexander DL, Yu B, et al
    CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation.
    PLoS Biol. 2018;16:e2005817.
    PubMed     Text format     Abstract available


    PLoS One

  23. LI H, Hai Y, Lim SY, Toledo N, et al
    Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.
    PLoS One. 2018;13:e0202997.
    PubMed     Text format     Abstract available

  24. MUNUSAMY PONNAN S, Swaminathan S, Tiruvengadam K, K K V, et al
    Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2018;13:e0203037.
    PubMed     Text format     Abstract available


  25. Retraction: A DNA inducing VLP vaccine designed for HIV and tested in mice.
    PLoS One. 2018;13:e0203635.
    PubMed     Text format    


    Science

  26. FRIEDEN TR
    Still not ready for Ebola.
    Science. 2018;360:1049.
    PubMed     Text format    


    Vaccine

  27. KILPI TM, Jokinen J, Puumalainen T, Nieminen H, et al
    Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.
    Vaccine. 2018 Aug 22. pii: S0264-410X(18)31129.
    PubMed     Text format     Abstract available

  28. HADJ MB, Bouguerra H, Saffar F, Chelly S, et al
    Observational study of vaccine effectiveness 20years after the introduction of universal hepatitis B vaccination in Tunisia.
    Vaccine. 2018 Aug 22. pii: S0264-410X(18)31167.
    PubMed     Text format     Abstract available

  29. NEWALL AT, Chen C, Wood JG, Stockwell MS, et al
    Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States.
    Vaccine. 2018 Aug 23. pii: S0264-410X(18)31114.
    PubMed     Text format     Abstract available

  30. WEDLOCK PT, Mitgang EA, Siegmund S, DePasse J, et al
    Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
    Vaccine. 2018 Aug 23. pii: S0264-410X(18)31135.
    PubMed     Text format     Abstract available

  31. COWLEY D, Nirwati H, Donato CM, Bogdanovic-Sakran N, et al
    Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.
    Vaccine. 2018 Aug 22. pii: S0264-410X(18)31136.
    PubMed     Text format     Abstract available

  32. POULOS C, Standaert B, Sloesen B, Stryjewska I, et al
    Preferences for vaccines against children's diarrheal illness among mothers in Poland and Hungary.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31108.
    PubMed     Text format     Abstract available

  33. STONE K, Akpalu Y, Horney J
    Use of the Community Assessment for Public Health Response (CASPER) method to assess influenza vaccination and activity in Brazos County, Texas.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31139.
    PubMed     Text format     Abstract available

  34. GONGAL G, Sampath G
    Introduction of intradermal rabies vaccination - A paradigm shift in improving post-exposure prophylaxis in Asia.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31163.
    PubMed     Text format     Abstract available

  35. WHITAKER JA, von Itzstein MS, Poland GA
    Strategies to maximize influenza vaccine impact in older adults.
    Vaccine. 2018 Aug 25. pii: S0264-410X(18)31169.
    PubMed     Text format     Abstract available

  36. SHIMIZU H, Seki K, Shiga K, Nakayama T, et al
    Safety and efficacy of DTaP-IPV vaccine use in healthcare workers for prevention of pertussis.
    Vaccine. 2018 Aug 25. pii: S0264-410X(18)31176.
    PubMed     Text format     Abstract available

  37. FOOKS AR, Banyard AC, Ertl HCJ
    New human rabies vaccines in the pipeline.
    Vaccine. 2018 Aug 25. pii: S0264-410X(18)31168.
    PubMed     Text format     Abstract available

  38. DONZELLI A, Duca P
    More than 70,000 deaths prevented by vaccination against three diseases in about 75years? The estimation seems exaggerated.
    Vaccine. 2018;36:5507.
    PubMed     Text format    

  39. PEZZOTTI P, Bellino S, Prestinaci F, Iacchini S, et al
    Reply to letters to the Editor: Bellavite P. Factors that influenced the historical trends of tetanus and diphtheria. Donzelli A, Duca P. More than 70,000 deaths prevented by vaccination against three diseases in about 75years? The estimation seems ex
    Vaccine. 2018;36:5508-5509.
    PubMed     Text format    

  40. MORINO S, Tanaka-Taya K, Satoh H, Arai S, et al
    Descriptive epidemiology of varicella based on national surveillance data before and after the introduction of routine varicella vaccination with two doses in Japan, 2000-2017.
    Vaccine. 2018 Aug 27. pii: S0264-410X(18)31177.
    PubMed     Text format     Abstract available

  41. PACI JT, Paci I
    The time has come for a Phase 3 trial of an Epstein-Barr virus vaccine.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31164.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: